Previous Chapter Chapter 15: Opportunities and Challenges in the Japanese Market for Cancer Therapies Next Chapter

By: Decision Resources Inc

In: The SAGE Handbook of Healthcare

Chapter 15: Opportunities and Challenges in the Japanese Market for Cancer Therapies

  • Citations
  • Add to My List
  • Text Size

Opportunities and Challenges in the Japanese Market for Cancer Therapies
Opportunities and challenges in the japanese market for cancer therapies
Overview

Since 1981, cancer has been the leading cause of death in Japan, and cancer mortality in that country has grown rapidly. Table 15.1 shows that the number of recorded deaths from cancers in Japan increased from 217,413 in 1990 to 320,358 in 2004, an increase of 47.3% in 14 years. In 2004, the death rate per 100,000 of population was 253.9, equivalent to 31.1% of the total number of deaths. According to the Ministry of Health, Labor, and Welfare (MHLW), cancers of the respiratory system (i.e., trachea, bronchus, lungs) were the most common causes of cancer-related mortality, followed by stomach and colorectal cancer.

The aging of the ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website